ARTICLE | Financial News
Mabworks raises RMB270M round
January 27, 2017 12:43 AM UTC
Mabworks Biotech Co. Ltd. (Beijing, China) raised RMB270 million ($39.4 million) in a round led by Shenzhen GTJA Investment Group, CEO Feng Li told BioCentury. New investor Harvest Capital Management also participated, as did existing investors Mefund Capital and Beijing E-Town Biomedical Park...
BCIQ Company Profiles